Previous studies demonstrated that KRAS mutation had a negative prognostic impact, especially in early stage lung cancer.26, 27 Here, we observed that NF1‐mutated patients showed significantly increased DFS and OS vs KRAS‐mutated patients in univariate analysis (Figure 3). The gene discussed is KRAS; the disease is lung carcinoma.